🕵️ Clorox Co /DE/ ($CLX)
SEC insider & ownership activity, last 12 months · CIK 21076 · every row links its SEC filing
Over the last 12 months insiders sold $1.9M against $846K of open-market buying. Eric Reynolds sold $1.9M in discretionary trades (Sep). Blackrock, Inc. trimmed 9.4% → 8.1%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $846K (2 lots) · 1 seller, $1.9M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Eric Reynolds | 0 | – | 1 | $1.9M | Sep 4, 2025 |
| Pierre R. Breber | 2 | $846K | 0 | – | May 5, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.1% | 13G | Jul 17, 2025 | filing ↗ | |
| Vanguard Capital Management | 7.3% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Eric Reynolds | $1.9M | Sep 4, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Other events (8.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 1, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 6, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Earnings (2.02) | Feb 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 17, 2026 | filing ↗ |
| Other events (8.01) | Jan 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Nov 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 19, 2025 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 27, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |